☰

Immunocore

Updating the operating model

Industry
Biotechnology
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Immunocore's published strategy and is not endorsed by, or produced in cooperation with, Immunocore. Company website

Strategic priorities

Immunocore operates across 4 stated priorities, with the most concrete near-term plan anchored on scale discovery excellence.

Accelerate identification of novel TCR therapeutics through digital tools and Genedata integration to expand the ImmTAX platform pipeline across oncology, infectious diseases, and autoimmune conditions.

Drive KIMMTRAK revenue growth through penetration into 24+ country markets with focus on US community oncology and German market expansion.

Execute Phase 3 TEBE-AM and ATOM trials for brenetafusp targeting 150,000+ solid tumor patients, with commercial manufacturing readiness at AGC Biologics by 2026.

Challenges we see

  • Operations Manufacturing

    CDMO Tech Transfer Complexity

    Immunocore operates a "virtual manufacturing" model relying entirely on CDMOs like AGC Biologics (Heidelberg) for late-phase clinical and commercial production. This creates critical dependency on smooth tech transfer from bench-scale R&D to GMP production.

    AGC Biologics notes that bench-scale methods often behave differently at production scale due to titration errors or protein precipitation, leading to extended PPQ timelines that jeopardize PRAME 2026 launch targets.

  • Digital Integration

    Joining records across systems

    The Milton Park R&D hub evolved from legacy buildings with fragmented equipment ecosystems. Many instruments lack cloud connectivity, forcing manual data entry and USB-based "Sneakernet" transfers between systems.

    The data team spends around 80% of its effort on data wrangling rather than AI model training, which limits how far the company can take advanced analytics for translational biomarker discovery.

  • Digital Integration

    IT/OT Convergence Gap

    A disconnect exists between "top-floor" IT systems managed by the CIO and "shop-floor" laboratory operations. Scientific data generated in R&D is not accessible for AI/ML applications due to lack of a unified Industrial Data Platform.

    Without standardized ontology-based data infrastructure, Immunocore is hard-pressed to capitalize on its data assets for predictive modeling and process optimization across the expanding pipeline.

  • Operations Operations

    Third-Party Supplier Risk

    The 2024 Annual Report identifies third-party supplier performance as a major risk factor. Without real-time OT connectivity to CDMO manufacturing systems, leadership lacks visibility into batch progress and potential disruptions.

    Geopolitical factors (Ukraine conflict, Middle East tensions) and supply chain disruptions could halt clinical trial site monitoring and commercial supply without early warning systems.

  • Compliance Regulatory

    Cybersecurity and Data Protection

    The Board's Audit and Compliance Committee has elevated cybersecurity to board-level oversight, indicating critical business risk. Immunocore's proprietary TCR sequences and clinical trial data represent high-value targets.

    Cyber incidents affecting internal or third-party IT systems could lead to operational disruptions, loss of proprietary IP, and revenue impact across the 24-country commercial footprint.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. AI-Ready Data Foundation

    The CIO is pursuing a Master's in AI but lacks the standardized, ontology-based data foundation needed to train models. 80% of team effort goes to data cleaning rather than value-generating analytics.

    Implement an Industrial Data Platform with semantic modeling to create AI-ready datasets, enabling 2x speed in data retrieval and automated pipeline generation for translational insights.

  2. CDMO Process Know-How Fragmentation

    Manufacturing knowledge is siloed between Immunocore's R&D scientists and CDMO engineers. No "Single Source of Truth" exists for bioprocess parameters, leading to extended PPQ timelines.

    Deploy a Process Digital Twin to capture and digitize process know-how, enabling virtual pre-validation of batches before sending protocols to AGC Biologics and reducing tech transfer friction.

  3. Manual Laboratory Data Entry

    Scientists at Milton Park rely on manual data entry and USB transfers between disconnected instruments. This "Sneakernet" approach increases audit risk and reduces turnaround times for experiments.

    Retrofit legacy equipment with IoT connectivity and implement automated data capture to eliminate manual transcription, achieving 65% reduction in data collection time and 100% data integrity for FDA/EMA audits.

  4. Real-Time Supply Chain Visibility

    Leadership lacks real-time visibility into CDMO batch progress, potential failures, or supply disruptions. Third-party supplier performance is identified as a major risk factor in annual reporting.

    Establish secure OT connectivity between Immunocore and CDMO manufacturing systems for real-time batch monitoring, enabling proactive risk mitigation and 30% reduction in PPQ delays.

  5. PRAME Throughput Scaling

    As the PRAME program expands to target 150,000+ patients, laboratory throughput for sample analysis must increase exponentially. Current manual cell counting is error-prone and time-consuming.

    Deploy ML-based computer vision for automated TCR-cell interaction counting, achieving 1-second analysis with 90%+ accuracy and freeing researchers to focus on translational insights rather than manual enumeration.

What we'd propose

  • Enterprise AI

    Industrial Data Platform for R&D Intelligence

    Deploy an ontology-driven data lakehouse architecture that unifies fragmented laboratory data sources into a single, AI-ready foundation with automated pipelines and semantic modeling.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI
  • Digital Lab

    Legacy Equipment Retrofitting Program

    Digitize the Milton Park R&D hub's legacy instruments through IoT sensor integration and control board controllers, enabling real-time cloud connectivity without capital replacement.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Digital CDMO

    Digital Twin for Bioprocess Optimization

    Create predictive simulation models of the PRAME production process to enable virtual experimentation and reduce physical batch failures during CDMO tech transfer.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Digital CDMO

    MTP-Based Modular Manufacturing Integration

    Implement Module Type Package (MTP) standards for media preparation and cell engineering systems, enabling "Plug & Produce" flexibility across CDMO partners.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Digital Lab

    ML-Powered Cell Analysis Automation

    Deploy computer vision and machine learning models for automated TCR-cell interaction analysis, replacing manual counting workflows and scaling laboratory throughput.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what Immunocore's own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Data Integration 35 → 80
Fragmented "data islands" with manual USB transfers; Genedata selection confirms internal systems insufficient
Lab Automation 40 → 85
Legacy instruments at Milton Park lack cloud connectivity; manual data entry prevalent
IT/OT Convergence 30 → 75
Clear disconnect between top-floor IT and shop-floor lab operations identified by CIO
Cybersecurity 50 → 85
Board-level oversight established; NIS2/IEC 62443 compliance needed for 24-country footprint
Process Analytics 45 → 90
Strong translational science capability but lack of real-time predictive modeling and Digital Twin infrastructure
ESG Monitoring 25 → 70
ESG scores "Under Review" by S&P Global; no real-time energy/water monitoring for 2025 targets

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Immunocore, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].